⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SNY News
Sanofi American Depositary Shares (Each representing one-half of one ordinary share)
IgE Receptor Antagonists Clinical Trial Pipeline Analysis: 12+ Key Companies Shaping the Future of IgE Receptor Antagonists Therapeutics | DelveInsight
globenewswire.com
AMRX
ARX
GSK
AZN
SNY
NVS
MRK
REGN
JNJ
PFE
BMY
LLY
VRTX
AMGN
ABBV
GILD
BIIB
CSL
AQST
RAPT
ALGT
Press Release: Sanofi launches 2026 global employee stock purchase plan
globenewswire.com
SNY
HSBC Continental Europe: Post Stabilisation Notice
globenewswire.com
SNY
HSBC
Global Drug Discovery Market Projected to Surpass USD 174.92 Billion by 2035 – SNS Insider
globenewswire.com
MRK
AZN
SNY
ROG
NVS
Press Release: Sanofi’s venglustat accepted for priority review in the US to treat type 3 Gaucher disease
globenewswire.com
SNY
Biomunex Announces Strategic Artificial Intelligence Collaborations to Further Accelerate the Discovery and Development Processes of Its Innovative Pipeline of Cancer Immunotherapies
businesswire.com
SNY
NMDP Gala in New York City Raises Record-Breaking $660,000 Enabling More Patients to Receive Life-Saving Cell Therapy
globenewswire.com
SNY
MSB
AMZN
MRK
GLP-1 Receptor Agonist Market Report 2026
globenewswire.com
NVO
SNY
LLY
Hepatitis A Market Research Report 2026-2036: Ecosystem, Marketed and Emerging Therapies, Epidemiological Analysis, Pipeline, Clinical Trial Landscape, Regulations Featuring GSK, Merck, and Sanofi
globenewswire.com
GSK
MRK
SNY
Late-Stage Chronic Kidney Disease Market Analysis Report 2026-2036, Profiles of Key Players - Novartis, Merck & Co, Pfizer, Sanofi, and Johnson & Johnson
globenewswire.com
AMGN
FMS
DVA
ABBV
NVS
MRK
PFE
SNY
JNJ